Thrombosis Risk for Normalized APC Sensitivity Ratios According to Sex
| Sex . | n-APC-SR . | Patients (%) . | Controls (%) . | ORcrude . | 95% CI . |
|---|---|---|---|---|---|
| Both sexes | >1.05 | 58 (17) | 156 (34) | 1* | |
| 0.99-1.05 | 68 (20) | 116 (25) | 1.6 | 1.0-2.4 | |
| 0.92-0.98 | 89 (26) | 108 (24) | 2.2 | 1.5-3.4 | |
| <0.92 | 122 (36) | 75 (16) | 4.4 | 2.9-6.6 | |
| Men (n = 333) | >1.10 | 21 (15) | 65 (33) | 1* | |
| 1.02-1.10 | 31 (23) | 55 (28) | 1.7 | 0.9-3.4 | |
| 0.95-1.01 | 36 (26) | 44 (22) | 2.5 | 1.3-4.9 | |
| <0.95 | 49 (36) | 32 (16) | 4.7 | 2.4-9.2 | |
| Women (n = 459) | >1.02 | 33 (16) | 87 (34) | 1* | |
| 0.96-1.02 | 45 (22) | 81 (31) | 1.5 | 0.9-2.5 | |
| 0.90-0.95 | 47 (23) | 54 (21) | 2.3 | 1.3-4.0 | |
| <0.90 | 75 (37) | 37 (14) | 5.3 | 3.0-9.4 |
| Sex . | n-APC-SR . | Patients (%) . | Controls (%) . | ORcrude . | 95% CI . |
|---|---|---|---|---|---|
| Both sexes | >1.05 | 58 (17) | 156 (34) | 1* | |
| 0.99-1.05 | 68 (20) | 116 (25) | 1.6 | 1.0-2.4 | |
| 0.92-0.98 | 89 (26) | 108 (24) | 2.2 | 1.5-3.4 | |
| <0.92 | 122 (36) | 75 (16) | 4.4 | 2.9-6.6 | |
| Men (n = 333) | >1.10 | 21 (15) | 65 (33) | 1* | |
| 1.02-1.10 | 31 (23) | 55 (28) | 1.7 | 0.9-3.4 | |
| 0.95-1.01 | 36 (26) | 44 (22) | 2.5 | 1.3-4.9 | |
| <0.95 | 49 (36) | 32 (16) | 4.7 | 2.4-9.2 | |
| Women (n = 459) | >1.02 | 33 (16) | 87 (34) | 1* | |
| 0.96-1.02 | 45 (22) | 81 (31) | 1.5 | 0.9-2.5 | |
| 0.90-0.95 | 47 (23) | 54 (21) | 2.3 | 1.3-4.0 | |
| <0.90 | 75 (37) | 37 (14) | 5.3 | 3.0-9.4 |
Reference category.